Home Newsletters Neural Cell News NOXXON Announces Enrollment of First Patient in the Expansion of the NOX-A12...

NOXXON Announces Enrollment of First Patient in the Expansion of the NOX-A12 Phase I/II Trial in Brain Cancer

By
Justin.choi
-
0
NOXXON Pharma N.V. announced that the first patient was enrolled in an expansion arm of the GLORIA clinical trial of NOX-A12 in MGMT unmethylated brain cancer.
[NOXXON Pharma N.V.]
6445212 nan items 1 apa 0 default asc 1 169831 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
Press Release

RELATED ARTICLES

Exit mobile version